Showing results (1-10 of 98) with videos related to
Sort By:
Pageof 10
The Journal of Antimicrobial Chemotherapy|December 11, 1999
Modified time-kill assay against multidrug-resistant Enterococcus faecium with novel antimicrobial combinationsC R Messick, K A Rodvold, S L PendlandDiagnostic Microbiology and Infectious Disease|December 24, 1997
In vitro activity of chloramphenicol alone and in combination with vancomycin, ampicillin, or RP 59500 (quinupristin/dalfopristin) against vancomycin-resistant enterococciC R Messick, S L PendlandDiagnostic Microbiology and Infectious Disease|November 21, 1998
In vitro activity of RPR 106972 alone and in combination with vancomycin, ampicillin, and gentamicin against multidrug-resistant enterococciC R Messick, J Woodward, S L PendlandThe Journal of Antimicrobial Chemotherapy|May 1, 1997
In-vitro activity of a new oral streptogramin, RPR 106972, alone and in combination with rifampicin or ciprofloxacin against Legionella sppS L Pendland, A D Killian, J G Woodward, et al.Cornea|July 1, 1997
Polyhexamethylene biguanide (PHMB) in the treatment of experimental Fusarium keratomycosisR G Fiscella, M Moshifar, C R Messick, et al.The Annals of Pharmacotherapy|April 9, 1998
Levofloxacin and sparfloxacin: new quinolone antibioticsS J Martin, J M Meyer, S K Chuck, et al.Antimicrobial Agents and Chemotherapy|November 26, 1997
Pharmacokinetics and pharmacodynamics of two multiple-dose piperacillin-tazobactam regimensD J Occhipinti, S L Pendland, L L Schoonover, et al.Antimicrobial Agents and Chemotherapy|February 19, 2000
Postantibiotic effects and bactericidal activities of clarithromycin-14-hydroxy-clarithromycin, versus those of amoxicillin-clavulanate, against anaerobesR Jung, C R Messick, S L Pendland, et al.Pharmacotherapy|January 1, 1988
Therapeutic considerations for infections caused by Staphylococcus epidermidisK A RodvoldPageof 10